首页> 外文期刊>Developmental Immunology: Journal of Immunology Research >Immune Suppression in Head and Neck Cancers: A Review
【24h】

Immune Suppression in Head and Neck Cancers: A Review

机译:头颈癌的免疫抑制:综述

获取原文
           

摘要

Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despite significant advances in the treatment modalities involving surgery, radiotherapy, and concomitant chemoradiotherapy, the 5-year survival rate remained below 50% for the past 30 years. The worse prognosis of these cancers must certainly be link to the fact that HNSCCs strongly influence the host immune system. We present a critical review of our understanding of the HNSCC escape to the antitumor immune response such as a downregulation of HLA class I and/or components of APM. Antitumor responses of HNSCC patients are compromised in the presence of functional defects or apoptosis of T-cells, both circulating and tumor-infiltrating. Langerhans cells are increased in the first steps of the carcinogenesis but decreased in invasive carcinomas. The accumulation of macrophages in the peritumoral areas seems to play a protumoral role by secreting VEGF and stimulating the neoangiogenesis.
机译:头颈部鳞状细胞癌(HNSCC)是世界第六大最常见的癌症。尽管涉及外科手术,放疗和伴随放化疗的治疗方式取得了重大进展,但过去30年的5年生存率仍低于50%。这些癌症的不良预后肯定与HNSCC强烈影响宿主免疫系统这一事实有关。我们对我们对HNSCC逃逸到抗肿瘤免疫反应(例如下调HLA I类和/或APM成分)的理解提出了重要的评论。 HNSCC患者的抗肿瘤反应在循环和肿瘤浸润的功能性缺陷或T细胞凋亡的存在下受到损害。朗格汉斯细胞在癌变的第一步增加,但在浸润性癌中减少。巨噬细胞在肿瘤周围区域的积累似乎通过分泌VEGF并刺激新血管生成而发挥了促癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号